Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Scleroproteins – e.g. – fibroin – elastin – silk – etc.
Patent
1995-06-06
1999-02-02
Huff, Sheela
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Scleroproteins, e.g., fibroin, elastin, silk, etc.
5303871, C07K 1600
Patent
active
058666885
ABSTRACT:
A method for production of a form-specific and/or inhibitory antibody against a cytochrome P450 protein is disclosed. The method includes the steps of selecting a cytochrome P450 protein for which a form-specific and/or inhibitory antibody is needed. The amino acid sequence of the selected cytochrome P450 protein is determined and aligned with a comparison amino acid sequence using an alignment algorithm. A peptide sequence corresponding to a region of a substrate recognition site is identified and a peptide of the selected sequence prepared. Using the peptide as an immunogen, an inhibitory and/or form-specific antibody is produced.
REFERENCES:
Oench et al. Anch. Biochem. Biophys. 270:23-32, 1989.
CRC Handbook of Biochem & Biophys, 3.sup.rd ed. vol. II, G. Fasman (ed), p. 84, 1976.
Friedman et al. Toxicologic Pathol. 12:155-61, 1984.
Letwe-Gonyon et al. vol. 119 No. 2 1984 pp. 744-750.
Bradford, "A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding" Anal. Biochem., 72:248-254 (1976).
Burke and Mayer, "Ethoxyresorufin: direct fluorimetric assay of microsomal o-dealkylation which is preferentially inducible . . . " Drug Metabl. Dispos., 2(6):583-588 (1974).
Chou and Fasman, "Prediction of protein conformation" Biochemistry, 13(2):222-244 (1974).
Edwards et al., "An anti-peptide antibody targeted to a specific region of rat cytochrome P-450IA2 inhibits enzyme activity" Biochem. J., 266:497-504 (1990).
Edwards et al., "Antipeptide antibodies in studies of cytochromes P451IA" in Methods in Enzymol., 206:220-233 (Academic Press, NY) (1991a).
Edwards et al., "Identification of a functionally conserved surface region of rat cytochromes P450IA" Biochem. J. (Sep.), 280:749-757 (1991b).
Frey et al., "The structure of phenonbarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4, Production and characterization . . . " J. Biol. Chem., 260:15253-15265 (1985).
Friedberg et al., "Production of site-specific P450 antibodies using recombinant fusion proteins as antigents" in Methods in Enzymol., 209:193-201 (Academic Press, NY) (1991).
Gotoh, "Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses . . . " J. Biol. Chem., 267:83-89 (1992).
Guengerich et al., "Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, . . . " Biochemistry, 21:6019-6030 (1982).
Kaul and Novak, "Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine" J. Pharmacol. Exp. Ther., 243:384-390 (1987).
Kawajiri et al., "Coding nucleotide sequence of 3-methylcholanthrene inducible cytochrome P-450d cDNA from rat liver" Proc. Natl. Acad. Sci., U.S.A., 81:1649-1653 (1984).
Kim et al., "Evidence for elevation of cytochrome P4502E1 (alcohol-inducible form) mRNA levels in rat kidney . . . " Biochem. Biophys. Res. Commun., 186:846-853 (1992).
Kim et al., "Enhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: differential induction . . . " Journal of Pharmacology and Exper. Therapeutics, 267:927-936 (1993).
Kyte and Doolittle, "Simple method for displaying hydorpathic character of a protein" J. Mol. Biol., 157:105-132 (1982).
Laemmli, "Cleavage of structural proteins during the assembly of head of bacteriophage T4" Nature (Aug.), 227:680-685 (1970).
Lubet et al., "Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochromes(s) . . . " Archiv. Biochem. Biophys. (Apr.), 238(1):43-48 (1985).
Mizukami et al., "Gene structure of phenobarbital-inducible cytochrome P-450 in rat liver" Proc. Natl. Acad. Sci. U.S.A., 80:3958-3962 (1983).
Murray et al., "Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies . . . " Carcinogenesis, 14:585-592 (1993).
Nelson et al., "The P450 superfamily: update on new sequences, gene mapping, accession numbers . . . " DNA and Cell Biol., 12(1):1-51 (1993).
Oda et al. "Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes" Biochem. Pharmacol., 38:4439-4444 (1989).
Omura and Sato, "Carbon monoxide-binding pigment of liver microsomes" J. Biol. Chem., 239:2379-2385 (1964).
Posnett et al., "A novel method for producing anti-peptide antibodies" J. Biol. Chem., 263(4):1719-1725 (1988).
Poulos, "Modeling of mammalian P450s on basis of P450cam X-ray structure" in Methods in Enzymol., 206:11-30 (Academic Press). (1991).
Poulos et al., "The 2.6-angstrom crystal structure of Pseudomonas putida cytochrome P-450" J. Biol. Chem., 260:16122-16130 (1985).
Poulos et al., "Crystal structure of substrate-free pseudomonas putida cytochrome P-450" Biochemistry, 25:5314-5322 (1986).
Reik et al., "A simple, non-chromatographic purification procedure for monoclonal antibodies" J. Immunol. Methods, 100:123-130 (1987).
Sesardic et al., "Inter-relatedness of some isoenymes of cytochrome P-450 from rat, rabbit and human . . . " Biochem. J., 236:569-577 (1986).
Symposium: Antibody-based therapeutics for cancer and autoimmune disease, FASEB Meeting, Apr. 5-9, 1992, Anaheim, CA.
Tam, "Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system" Proc. Natl. Acad. Sci. U.S.A., 85:5409-5413 (1988).
Unger et al., "Nucleotide sequence of the Pseudomonas putida cytochrome P-450cam gene and its expression in Escherichia coli" J. Biol. Chem., 261:1158-1163 (1986).
Waxman and Walsh, "Phenobarbital-induced rat liver cytochrome P-450: purification and characterization of two closely related . . . " J. Biol. Chem., 257:10446-10457 (1982).
Waxman et al., "Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome . . . " J. Biol. Chem., 258:11937-11947 (1983).
Yabusaki et al., "Nucleotide sequence of a full-length cDNA coding for 3-methylcholanthrene-induced rat liver . . . " Nucleic Acids Res., 12:2929-2938 (1984).
Yuan et al., "Identification and localization of amino acid substitutions between two pheonobarbital . . . " Proc. Natl. Acad. Sci. USA, 80:1169-1173 (1983).
Guengerich, "Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes" Chemical Research in Toxicology, vol. 4, No. 4, pp. 391-407 (1991).
Murray and Reidy, "Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents" Pharmacological Reviews, vol. 42, No. 2, pp. 85-99 (1990).
Sesardic et al., "A form of cytochrom P450 in man, orthologous to form d in the rat . . . " Br. J. Clin. Pharmac., 26:363-372 (1988).
Symposium: 10th Intl. on Microsomes and Drug Oxidations, Toronto, Canada, Jul. 18-21, 1994 (Abstract) Kim et al. "Production and characterization of inhibitory . . . ".
Charnecki Jonathan
Kim Edward Y.
Kim Hyesook
Putt David A.
Huff Sheela
Oxford Biomedical Research, Inc.
LandOfFree
Production of anti-peptide antibodies against cytochrome P450 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of anti-peptide antibodies against cytochrome P450, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of anti-peptide antibodies against cytochrome P450 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1118466